Investor Backing & Capital Strength:
Late-stage funding rounds—an $88M Series C (2024) and a $150M Series D (2026) led by top-tier firms at a roughly $3B valuation—provide runway for hiring, product development, and broader go-to-market. Feedback suggests this capital base signals strong sponsor conviction and supports continued scaling.
Strong Revenue Growth:
Coverage highlights revenue rising from low single-digit millions in 2021 to hundreds of millions by 2024, with subsequent reports indicating around $1B in 2025 alongside surging appointment volumes. Inclusion on the FT/Statista fastest‑growing list reinforces the trajectory.
Market Expansion:
Expansion to 125+ insurer partnerships, a nationwide network of roughly 26,000 providers, and new channels with employers and health systems indicate broader distribution. Rising utilization—7M visits in 2025 and 10M lifetime appointments—supports an expanding footprint.
.png)
.png)
